OBM Genetics,
Год журнала:
2024,
Номер
08(04), С. 1 - 25
Опубликована: Ноя. 20, 2024
Microbial
and
viral
pathogens
have
emerged
as
pivotal
agents
in
oncogenesis.
Research
conducted
the
last
twenty
years
has
significantly
enhanced
our
comprehension
of
cancer-causing
capabilities
infectious
agents.
An
illustrative
instance
is
gastric
cancer
(GC),
which
closely
associated
with
Helicobacter
pylori
(H.
pylori)
Epstein-Barr
virus
(EBV)
infections.
Despite
concerted
endeavors,
GC
remains
a
serious
clinical
challenge
ranking
fifth
most
commonly
diagnosed
worldwide.
In
2020,
an
estimated
768,793
people
died
from
world.
The
pathogenicity
island
(PAI),
cagA
protein,
VacA
other
virulence
factors
H.
several
latency
such
EBNA-1,
LMP-1
LMP2A
well
pattern
gene
methylation
EBV
co-infection
are
shown
main
causes
pathogen-related
GC.
unique
molecular
characteristics
GC,
highlight
importance
further
understanding
their
respective
roles
development
progression.
This
knowledge
may
inform
future
preventive
therapeutic
strategies
targeting
these
context
review
aims
to
elucidate
mechanisms
underpinning
pylori-induced
carcinogenesis
Helicobacter
pylori
strains
can
be
broadly
classified
into
two
groups
based
on
whether
they
contain
or
lack
a
chromosomal
region
known
as
the
cag
pathogenicity
island
(cag
PAI).
Colonization
of
human
stomach
with
PAI-positive
is
associated
an
increased
risk
gastric
cancer
and
peptic
ulcer
disease,
compared
to
colonization
PAI-negative
strains.
The
PAI
encodes
secreted
effector
protein
(CagA)
components
type
IV
secretion
system
(Cag
T4SS)
that
delivers
CagA
non-protein
substrates
host
cells.
Animal
model
experiments
indicate
Cag
T4SS
stimulate
mucosal
inflammatory
response
contribute
development
cancer.
In
this
review,
we
discuss
recent
studies
defining
structural
functional
features
mechanisms
by
which
H.
containing
promote
disease.
Journal of Hematology & Oncology,
Год журнала:
2025,
Номер
18(1)
Опубликована: Янв. 23, 2025
Gastric
cancer
remains
a
significant
global
health
challenge,
with
Helicobacter
pylori
(H.
pylori)
recognized
as
major
etiological
agent,
affecting
an
estimated
50%
of
the
world's
population.
There
has
been
rapidly
expanding
knowledge
molecular
and
pathogenetic
mechanisms
H.
over
decades.
This
review
summarizes
latest
research
advances
to
elucidate
underlying
infection
in
gastric
carcinogenesis.
Our
investigation
reveals
complex
network
involving
STAT3,
NF-κB,
Hippo,
Wnt/β-catenin
pathways,
which
are
dysregulated
caused
by
pylori.
Furthermore,
we
highlight
role
inducing
oxidative
stress,
DNA
damage,
chronic
inflammation,
cell
apoptosis—key
cellular
events
that
pave
way
for
Emerging
evidence
also
suggests
effect
on
tumor
microenvironment
its
possible
implications
immunotherapy.
synthesizes
current
identifies
gaps
warrant
further
investigation.
Despite
progress
our
previous
development
pylori-induced
cancer,
comprehensive
pylori's
is
crucial
advancement
prevention
treatment
strategies.
By
elucidating
these
mechanisms,
aim
provide
more
in-depth
insights
study
pylori-related
cancer.
ABSTRACT
Helicobacter
pylori
,
a
gram‐negative
microaerophilic
bacterium,
is
implicated
in
broad
spectrum
of
upper
gastrointestinal
disorders,
including
chronic
gastritis,
peptic
ulcers,
gastric
cancer,
and
even
certain
extragastric
diseases.
Its
ability
to
colonize
persist
within
the
host
driven
by
complex
arsenal
colonization
virulence
factors,
underscoring
intricate
dynamics
host–pathogen
interactions.
The
clinical
management
H.
remains
challenging,
primarily
due
absence
commercially
available
vaccines
increasing
prevalence
multidrug
resistance.
Accurate
reliable
detection
methods
are
therefore
critical
for
preventing
infections,
identifying
antibiotic
resistance,
assessing
treatment
efficacy.
Currently,
both
invasive
non‐invasive
diagnostic
approaches
employed,
each
with
unique
strengths
limitations.
This
review
provides
comprehensive
overview
pathogenesis,
strategies,
therapeutic
interventions,
highlighting
latest
advancements
technologies.
By
critically
evaluating
existing
exploring
innovative
approaches,
this
aims
support
future
progress
effective
globally
prevalent
pathogen.
ABSTRACT
Helicobacter
pylori
colonization
of
the
human
stomach
is
a
strong
risk
factor
for
gastric
cancer.
To
investigate
H.
-induced
molecular
alterations,
we
used
Mongolian
gerbil
model
carcinogenesis.
Histologic
evaluation
revealed
varying
levels
atrophic
gastritis
(a
premalignant
condition
characterized
by
parietal
and
chief
cell
loss)
in
-infected
animals,
transcriptional
profiling
loss
markers
these
types.
We
then
assessed
spatial
distribution
relative
abundance
proteins
tissues
using
imaging
mass
spectrometry
liquid
chromatography
with
tandem
spectrometry.
detected
striking
differences
protein
content
corpus
antrum
tissues.
Four
hundred
ninety-two
were
preferentially
localized
to
uninfected
animals.
The
91
was
reduced
exhibiting
compared
infected
non-atrophic
or
tissues;
included
numerous
metabolic
functions.
Fifty
animals
diffusely
delocalized
throughout
gastritis;
roles
processing.
corresponding
alterations
not
∆
cagT
mutant
(lacking
Cag
type
IV
secretion
system
activity).
These
results
indicate
that
can
cause
normally
as
well
diffuse
delocalization
corpus-specific
proteins,
resulting
marked
changes
normal
partitioning
into
distinct
regions.
IMPORTANCE
A
organized
regions
known
antrum,
which
have
different
functions,
types,
gland
architectures.
Previous
studies
primarily
histologic
methods
differentiate
detect
leading
In
this
study,
investigated
report
detection
are
but
stomach.
show
stomachs
pylori-
induced
precancerous
specialized
types)
exhibit
localization
corpus.
provide
new
insights
associated
development
_Helicobacter
pylori_
(_H.
pylori_),
a
bacteria
which
chronically
infects
the
stomach
of
approximately
half
people
in
world,
is
risk
factor
for
development
gastric
cancer
(GC).
However,
detailed
mechanism
by
_H.
infection
induces
GC
remains
unclear.
Intermittent
injection
CagA
protein
to
its
host
cell,
inhibits
nuclear
translocation
BRCA1/BRCA2-the
DNA
repair
proteins
involved
prominently
breast
development.
Interestingly,
hereditary
and
ovarian
syndrome
(HBOC)
associated
with
Here,
we
aimed
understand
molecular
link
between
infection,
_BRCA1/2_
pathogenic
variants
(PVs),
higher
incidence
HBOC
families.
To
do
so,
this
retrospective
clinical
observation
study,
checked
database
Japanese
patients
undergoing
precision
treatment
using
genomic
medicine.
Indeed,
found
families
having
germline
(GPVs)
(2.95
%
vs.
0.78%
(in
non-HBOC
families).
Next
we,
that
96.1
infected
received
medicine
examination
advanced
GC,
>
16%
had
_gBRCA2_
PVs.
Moreover,
histological
tumor
tissue
showed
mucosa
epithelial
cells
CagA-positive
strains
were
lacking
BRCA1.
Further,
expressing
wildtype
BRCA1/2
_Gan_
mice
(a
mouse
model
human
GC),
inhibited
Thus,
_gBRAC1/2_
PVs
synergistically
increase
Our
study
thus
highlights
need
early
eradication
pylori
_infection
family
members
prevent
it
indicates
poly(ADP-ribose)
polymerases
(PARPs)
inhibitors
will
be
effective
halting
progression
GCs
_gBRCA1/2_